Menu

GRenSSAP
Grup de recerca en Investigació en Serveis

Group leader
Anna_Berenguera 400
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Projects

Group projects

Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID -19) Vaccine

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/037
  • Start year: 2021
  • Funders: Fondazione Penta ETS

Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (WP1)

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/109
  • Start year: 2021
  • Funders: European Medicines Agency (EMA)

Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R22/073
  • Start year: 2022
  • Funders: UMC Utrecht (University Medical Center Utrecht)

Estudio posautorización de seguridad (EPAS) no intervencionista para la vigilancia activa de la seguridad de los receptores de la vacuna de ARNm contra la COVID-19 de Pfizer-BioNTech en la UE

  • Principal investigators: Sonia Olías Bretones, Cristina Alcaide Moreno, Felipe Villalobos Martínez
  • Code: 5O21/003
  • Start year: 2021

Post-Authorisation Active Surveillance Study of Myocarditis and Pericarditis Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID 19) Vaccine

  • Principal investigators: Bonaventura Bolíbar Ribas, Felipe Villalobos Martínez
  • Code: 4R22/078
  • Start year: 2022
  • Funders: Fondazione Penta ETS

Board of Trustees

Collaborators

Accreditations